Figure 6.

Effects of selective peroxisome proliferator-activated receptor (PPAR) agonists on serum deprivation (SD)-induced podocyte apoptosis. Cells were treated with either gemfibrozil (1 nM–30 µM, A), GW0742 (0.01 nM–300 nM, B), pioglitazone (0.3 nM–10 µM, C) or rosiglitazone (0.03nM–3 µM, D) as single or repeated treatment, and then exposed to SD (48 h). Results are expressed as mean ± SEmean of five experiments run in triplicate.